Neptune Wellness Solutions (NASDAQ:NEPT) Trading 9.7% Higher

Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB)’s share price traded up 9.7% on Wednesday . The company traded as high as $4.65 and last traded at $4.65, 1,731,200 shares changed hands during mid-day trading. An increase of 85% from the average session volume of 937,459 shares. The stock had previously closed at $4.24.

NEPT has been the topic of a number of research reports. ValuEngine cut shares of Neptune Wellness Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday. Zacks Investment Research cut Neptune Wellness Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday, August 20th. BidaskClub downgraded Neptune Wellness Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, August 28th. Finally, Echelon Wealth Partners restated a “buy” rating on shares of Neptune Wellness Solutions in a research report on Wednesday, July 24th.

The stock has a market capitalization of $392.90 million, a price-to-earnings ratio of -33.21 and a beta of 1.85. The stock has a 50 day moving average price of $4.74 and a 200 day moving average price of $4.21.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last released its quarterly earnings data on Wednesday, August 14th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.03). The firm had revenue of $3.26 million during the quarter, compared to analyst estimates of $4.51 million. Neptune Wellness Solutions had a negative net margin of 107.62% and a negative return on equity of 23.18%. As a group, equities analysts expect that Neptune Wellness Solutions Inc will post 0.01 earnings per share for the current year.

A number of institutional investors and hedge funds have recently bought and sold shares of NEPT. Alpine Group USVI LLC acquired a new position in Neptune Wellness Solutions in the 1st quarter valued at approximately $303,000. Signition LP bought a new stake in shares of Neptune Wellness Solutions in the second quarter worth $87,000. CIBC World Markets Inc. bought a new stake in shares of Neptune Wellness Solutions in the first quarter worth $63,000. Morgan Stanley increased its holdings in Neptune Wellness Solutions by 9.1% in the second quarter. Morgan Stanley now owns 208,980 shares of the biotechnology company’s stock valued at $909,000 after purchasing an additional 17,361 shares during the period. Finally, Tower Research Capital LLC TRC increased its holdings in Neptune Wellness Solutions by 265.7% in the second quarter. Tower Research Capital LLC TRC now owns 9,929 shares of the biotechnology company’s stock valued at $43,000 after purchasing an additional 7,214 shares during the period. 11.86% of the stock is currently owned by hedge funds and other institutional investors.

About Neptune Wellness Solutions (NASDAQ:NEPT)

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Read More: Quick Ratio

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.